Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program

Cancer

Volumn 119, Issue SUPPL. 15, 2013, Pages 2855-2862

  Subramanian, Sujha ^a   Tangka, Florence K L ^b   Hoover, Sonja ^a   Beebe, Maggie C ^a   Degroff, Amy ^b   Royalty, Janet ^b   Seeff, Laura C ^b  

^a RTI INTERNATIONAL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

cancer screening programs; clinical costs; colorectal cancer; cost assessment; nonclinical costs

Indexed keywords

ARTICLE; CANCER SCREENING; CENTERS FOR DISEASE CONTROL AND PREVENTION; COLORECTAL CANCER; COLORECTAL CANCER SCREENING DEMONSTRATION PROGRAM; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH ECONOMICS; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MEDICAL INFORMATION; PRIORITY JOURNAL;

CANCER SCREENING PROGRAMS; CLINICAL COSTS; COLORECTAL CANCER; COST ASSESSMENT; NONCLINICAL COSTS;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COLORECTAL NEOPLASMS; DELIVERY OF HEALTH CARE; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; HEALTH CARE COSTS; HUMANS; QUESTIONNAIRES; UNITED STATES;

EID: 84880535653     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28158     Document Type: Article

References (19)

1. Seeff LC, DeGroff A, Tangka F, et al. Development of a federally funded demonstration colorectal cancer screening program [serial online]. Prev Chronic Dis. 2008; 5: A64.
2. Tangka FK, Subramanian S, Bapat B, et al. Cost of starting colorectal cancer screening programs: results from 5 federally funded demonstration programs [serial online]. Prev Chronic Dis. 2008; 5: A47.
3. DeGroff A, Holden D, Goode Green S, Boehm J, Seeff LC, Tangka F,. Start-up of the colorectal cancer screening demonstration program [serial online]. Prev Chronic Dis. 2008; 5: A38.
4. Seeff LC, Royalty J, Helsel WE, et al. Clinical outcomes from CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (suppl 15): 2820-2833.
5. Centers for Disease Control and Prevention (CDC). Colorectal Cancer Clinical Data Elements. Atlanta, GA: CDC; 2012. Available at: http://www.cdc.gov/cancer/crccp/pdf/CCDE-Data-DefinitiontableOMB-T.pdf. [Accessed January 15, 2012.]
6. Vijan S, Hwang I, Inadomi J, et al. The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol. 2007; 102: 380-390.
7. Subramanian S, Bobashev G, Morris RJ,. Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1971-1978.
8. Pignone M, Russell L, Wagner J, eds. Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary. Washington, DC: Institute of Medicine and National Research Council; 2005.
9. Zauber A, Lansdorp-Vogelaar I, Wilschut J, van Ballegooijen M, Kuntz K,. Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer: Report to AHRQ and CMS from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC Models. Rockville, MD: Agency for Healthcare Research and Quality; 2007.
10. Tangka FKL, Subramanian S, Beebe MC, Hoover S, Royalty J, Seeff LC,. Clinical costs of colorectal cancer screening in five federally funded demonstration programs. Cancer. 2013; 119 (suppl 15): 2863-2869.
11. Subramanian S, Ekwueme DU, Gardner JG, Bapat B, Kramer C,. Identifying and controlling for program-level differences in comparative cost analysis: lessons from the economic evaluation of the National Breast and Cervical Cancer Early Detection Program. Eval Program Plann. 2008; 31: 136-144.
12. Anderson DW, Bowland BJ, Cartwright WS, Bassin G,. Service-level costing of drug abuse treatment. J Subst Abuse Treat. 1998; 15: 201-211.
13. French MT, Dunlap LJ, Zarkin GA, McGeary KA, McLellan AT,. A structured instrument for estimating the economic cost of drug abuse treatment: the Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat. 1997; 14: 445-455.
14. Salome HJ, French MT, Miller M, McLellan AT,. Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP). Drug Alcohol Depend. 2003; 71: 195-206.
15. Drummond M, Schulpher M, Torrance G, O'Brien B, Stoddard G, eds. Methods for the Economic Evaluation of Health Care Programme. 3rd ed. Oxford, United Kingdom: Oxford University Press; 2005.
16. Castro G, Seeff L, Azrak F, et al. Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis. Cancer. 2013; 119 (suppl 15): 2849-2854.
17. US Bureau of Labor Statistics. Consumer Price Index for All Urban Consumers (CPI-U): Regions, by Expenditure Category and Commodity and Service Group. Washington, DC: US Bureau of Labor Statistics; 2008.
18. Swan J, Breen N, Graubard BI, et al. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer. 2010; 116: 4872-4881.
19. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54: 78-93.